TREA

90382648 - SANGENTRI

Follow

Information

  • Trademark
  • 90382648
  • Serial Number
    90382648
  • Filing Date
    December 15, 2020
    4 years ago
  • Transaction Date
    July 12, 2024
    6 months ago
  • Status Date
    June 03, 2024
    8 months ago
  • Published for Opposition Date
    July 13, 2021
    3 years ago
  • Location Date
    November 02, 2021
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CLARKE, NANCY L
  • Attorney Name
    Maury M. Tepper, III
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4
Mark Identification
SANGENTRI
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
Case File Event Statements
  • 12/18/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/23/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/29/2021 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/31/2021 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/31/2021 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/31/2021 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/3/2021 - 3 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/3/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/3/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/4/2021 - 3 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/23/2021 - 3 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/13/2021 - 3 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/13/2021 - 3 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/11/2021 - 3 years ago
    14 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 9/22/2021 - 3 years ago
    15 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 11/2/2021 - 3 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/1/2022 - 2 years ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/27/2022 - 2 years ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/27/2022 - 2 years ago
    18 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/27/2022 - 2 years ago
    19 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 4/29/2022 - 2 years ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/1/2022 - 2 years ago
    22 - SOU EXTENSION 2 FILED Type: EXT2
  • 11/1/2022 - 2 years ago
    23 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/27/2023 - a year ago
    29 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/27/2023 - a year ago
    30 - SOU EXTENSION 4 FILED Type: EXT4
  • 10/27/2023 - a year ago
    31 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 6/3/2024 - 8 months ago
    33 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/12/2024 - 6 months ago
    34 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 10/31/2023 - a year ago
    32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/3/2022 - 2 years ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 4/18/2023 - a year ago
    25 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/18/2023 - a year ago
    26 - SOU EXTENSION 3 FILED Type: EXT3
  • 4/18/2023 - a year ago
    27 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 4/20/2023 - a year ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA